Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries

Essential medicines for COPD and asthma in low and middle-income countries

“…4 Lack of availability of inhaled corticosteroids (as the most effective controller medication) was repetitively reported in public sector health facilities while it was selected in over 90% of the NEMLs in our study. In the private sector, the situation is more promising.…”

Epidemiology of Cardiovascular Risk Factors in Asian Countries

“…In other low-and middle-income Asian countries, undiagnosed and untreated hypertension is likely more common, considering the background conditions of limited access to effective treatments and care for chronic diseases. 31 Evidence from a large community-dwelling sample of 65,000 Japanese men and women suggests that a considerable proportion of CVD deaths could have been avoided had proper measures been taken to maintain healthy BP levels (systolic/diastolic BP <120/80 mmHg) through their lifestyle (Figure 2). 32 This illustrates the importance of primary prevention of hypertension regardless of age.…”

The global fund for epilepsy: A proposal

“…Inexpensive older-generation antiepileptic drugs manufactured in India are widely available but stocked in less than one-third of public sector facilities in developing countries. 6 International funding for epilepsy-specific programs providing patient care, treatment, and support is extremely limited. A number of neurologic organizations and societies engage in short-term training exchanges, research mentoring, courses, and symposia but do not have the financial or human resources to support large-scale sustainable projects for treating PLWE in resource-limited countries.…”